Clearmind Medicine Inc. Common Shares Total Assets
Clearmind Medicine Inc. Common Shares total assets. Based on the latest financial reports, Clearmind Medicine Inc. Common Shares (CMND) holds total assets worth $11.14 Million USD as of January 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Clearmind Medicine Inc. Common Shares market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Clearmind Medicine Inc. Common Shares (2014–2025)
Total assets of Clearmind Medicine Inc. Common Shares from 2014 to 2025. This chart illustrates how Clearmind Medicine Inc. Common Shares's total assets have evolved over time, based on quarterly financial data. See CMND stock price and chart for real-time trading data and today's change.
Clearmind Medicine Inc. Common Shares - Asset Composition Analysis
Clearmind Medicine Inc. Common Shares Total Assets Breakdown (October 2025)
Clearmind Medicine Inc. Common Shares total assets breakdown as of October 2025. Clearmind Medicine Inc. Common Shares's total assets of $11.14 Million consist of 97.8% current assets and 2.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 64.5% |
| Accounts Receivable | $322.28K | 5.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $97.36K | 1.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Clearmind Medicine Inc. Common Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Clearmind Medicine Inc. Common Shares to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Clearmind Medicine Inc. Common Shares's current assets represent 97.8% of total assets in 2025, a decrease from 100.0% in 2014.
- Cash Position: Cash and equivalents constituted 64.5% of total assets in 2025, up from 27.7% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 5.3% of total assets.
Clearmind Medicine Inc. Common Shares Competitors by Total Assets
Key competitors of Clearmind Medicine Inc. Common Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
HLB Co. Ltd
KQ:028300
|
Korea | ₩925.44 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Shanghai Medicilon Inc
SHG:688202
|
China | CN¥2.88 Billion |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
India | Rs16.41 Billion |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767
|
China | CN¥2.49 Billion |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
|
China | CN¥725.73 Million |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880
|
China | CN¥3.67 Billion |
Clearmind Medicine Inc. Common Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.79 | 1.72 | 7.56 |
| Quick Ratio | 3.79 | 1.72 | 7.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $8.11 Million | $3.97 Million | $165.06K |
Clearmind Medicine Inc. Common Shares - Advanced Valuation Insights
This section examines the relationship between Clearmind Medicine Inc. Common Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.75 |
| Latest Market Cap to Assets Ratio | 0.92 |
| Asset Growth Rate (YoY) | -39.8% |
| Total Assets | $6.08 Million |
| Market Capitalization | $5.61 Million USD |
Valuation Analysis
Near Book Valuation: The market values Clearmind Medicine Inc. Common Shares's assets close to their book value (0.92x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Clearmind Medicine Inc. Common Shares's assets decreased by 39.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Clearmind Medicine Inc. Common Shares (2014–2025)
The table below shows the annual total assets of Clearmind Medicine Inc. Common Shares from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-10-31 | $6.08 Million | -39.77% |
| 2024-10-31 | $10.10 Million | +69.65% |
| 2023-10-31 | $5.95 Million | +430.74% |
| 2022-10-31 | $1.12 Million | -73.05% |
| 2021-10-31 | $4.16 Million | +981.80% |
| 2020-10-31 | $384.81K | +184.04% |
| 2019-10-31 | $135.47K | -27.96% |
| 2018-10-31 | $188.06K | +86.86% |
| 2017-10-31 | $100.65K | +2241.17% |
| 2016-10-31 | $4.30K | +1492.22% |
| 2015-10-31 | $270.00 | -97.89% |
| 2014-10-31 | $12.79K | -- |
About Clearmind Medicine Inc. Common Shares
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It d… Read more